The EU’s political leaders have made dramatic policy reversals in recent days that reflect a more reasoned approach than in the past. As noted previously, they have scrapped some of the Green Deal/Farm to Fork requirements like quitting pesticides, and today the EU Parliament (EP) approved releasing NGT-1 products from the obligations of the Novel Foods Directive. This means that new crop traits developed through new genomic techniques and considered to be “indistinguishable” from conventional crops avoid the most burdensome requirements. The EP voted approval (307 for, 263 against, 41 abstained) despite anti-GMO advocacy groups insisting that it would mean GMO’s released into use without any requirements for...
Infrastructure investment due diligence
On behalf of a Canadian oilseed processer WPI's team provided market analysis, econometric modeling and financial due diligence in support of a $24 million-dollar investment in a Ukrainian crush plant. Consistent with WPI's findings, local production to supply the plant and the facility's output have expanded exponentially since the investment. WPI has conducted parallel work on behalf of U.S., South American and European clients, both private and public, in the agri-food space.
A bipartisan group of 26 lawmakers, led by Representative David Valadao (R-CA), sent a letter to House Speaker Mike Johnson (R-Louisiana) and House Agriculture Committee Chair GT Thompson (R-Pennsylvania) requesting that $5 billion of the temporary economic assistance for farmers go toward spec...
Agriculture generates a lot of numbers in addition to crops and livestock. As ag economists, we are continually reviewing crop production, commodity prices, farm incomes, and international trade. You don’t often see much about capital investment in the ag press, however. New mills and gra...
Oliver Goldsmith's The Deserted Village, published in 1770, is of a timeless quality. It is a 425-line lament for a disappearing rural world, where prosperous villages give way to larger estates, fewer farmers, and emigration. One passage even follows those leaving for the new colony of Georgia...
The industry has spent two years bracing for GLP-1 medications to hollow out demand, but the data so far tells a more interesting story. Roughly one in eight adults currently uses a GLP-1, and an additional 29 percent of non-users say they would consider it if it became more accessible and cost...